Little is known about the burden of sepsis in Canada. A fundamental factor is the ongoing debate on 'what is sepsis?'. Clinicians struggle to identify it; moreover, clinical identification of infection has a false-positive rate >40%. The various iterations of the consensus definition since the mid 1990s indicate diagnostic uncertainty and evolving conceptualization. Team 1 will work to resolve 4 key issues: (1) uncertainty about the population incidence of sepsis; (2) inadequate knowledge about risk factors and outcomes; (3) heterogeneity and limited accessibility of sepsis datasets distributed throughout the country; and (4) lack of knowledge on the economic consequences of sepsis.
Projects 1, 2 and 3 create infrastructure to study the clinical epidemiology of sepsis. Project 4 illustrates the value of these core infrastructures, evaluating the links between sepsis, and diabetes and obesity. Project 5 builds infrastructure necessary to understand the societal economic losses attributable to sepsis, and to identify populations in whom interventions would maximize health gains and cost savings for society.
Projects
- Project 1: Improving the Identification of Sepsis
- Project 2: Creation of a Metadata Catalog and Platform for Sepsis Epidemiology Studies
- Project 3: Scoping Review and Cataloguing of Existing Knowledge about the Epidemiology of Sepsis
- Project 4: The Impact of Diabetes on Sepsis-Associated Clinical Outcomes
- Project 5: The Economic Costs of Sepsis
Team 1 Leads/Mentors
Dr. Kali Barrett
University of Toronto
Dr. Isabel Fortier
McGill University
Dr. Allan Garland
University of Manitoba
Dr. Margaret Herridge
University of Toronto
Dr. Claudio Martin
Western University
Dr. Hallie Prescott
University of Michigan
Dr. Bram Rochwerg
McMaster University
Dr. Damon Scales
University of Toronto
Dr. Kednapa Thavorn
University of Ottawa
Dr. Elizabeth Wilcox
University of Alberta
